# AI QUALITY CHECK RESULTS

**Reviewer:** AI Final-Pass Quality Checker
**Date:** February 24, 2026
**Documents Reviewed:**
1. `01_Go_No_Go_Report.md` (Go/No-Go Decision Report)
2. `02_Software_Action_Plan.md` (Software Development Action Plan)
3. `04_White_Paper.md` (White Paper)

**Classification:** CUI | Internal Consortium Only

---

## SUMMARY

| Category | Critical | Major | Minor | Info |
|---|---|---|---|---|
| Placeholder Detection | 4 | 0 | 0 | 0 |
| Cross-Document Consistency | 2 | 2 | 1 | 0 |
| Accuracy / Contradictions | 0 | 3 | 1 | 0 |
| Grammar & Spelling | 0 | 0 | 3 | 0 |
| Formatting | 0 | 1 | 3 | 0 |
| Tone | 0 | 0 | 0 | 1 |
| Completeness | 1 | 2 | 1 | 0 |
| **TOTAL** | **7** | **8** | **9** | **1** |

---

## 1. PLACEHOLDER DETECTION (CRITICAL)

### ISSUE P-1: White Paper -- Point of Contact name is a placeholder
- **File:** `04_White_Paper.md`, Line 13
- **Text:** `| Point of Contact | [Name], Chief Executive Officer |`
- **Issue:** `[Name]` is unfilled placeholder text. This will be immediately disqualifying if submitted as-is.
- **Fix:** Replace `[Name]` with the actual CEO name of Veteran Vectors LLC.

### ISSUE P-2: White Paper -- Phone number is a placeholder
- **File:** `04_White_Paper.md`, Line 15
- **Text:** `| Phone | [Phone] |`
- **Issue:** `[Phone]` is unfilled placeholder text.
- **Fix:** Replace `[Phone]` with the actual contact phone number.

### ISSUE P-3: White Paper -- CAGE Code is a placeholder
- **File:** `04_White_Paper.md`, Line 16
- **Text:** `| CAGE Code | [CAGE] |`
- **Issue:** `[CAGE]` is unfilled placeholder text. CAGE codes are required for DoD contracting.
- **Fix:** Replace `[CAGE]` with the company's actual CAGE code (5-character alphanumeric).

### ISSUE P-4: White Paper -- DUNS number is a placeholder
- **File:** `04_White_Paper.md`, Line 17
- **Text:** `| DUNS | [DUNS] |`
- **Issue:** `[DUNS]` is unfilled placeholder text. Note: DUNS has been replaced by the Unique Entity ID (UEI) in SAM.gov as of April 2022. This field label may itself need updating depending on what the solicitation requests.
- **Fix:** Replace `[DUNS]` with the actual identifier. If the solicitation requests a UEI (which is current practice), change the field label from "DUNS" to "UEI" and provide the SAM.gov Unique Entity ID.

---

## 2. CROSS-DOCUMENT CONSISTENCY

### ISSUE C-1 (CRITICAL): Software development cost mismatch between Go/No-Go and Software Action Plan
- **File:** `01_Go_No_Go_Report.md`, Line 95
- **Text:** `Software development ($506K) + 30 prototype units (30 x $3,500 = $105K) | ~$611,000`
- **File:** `02_Software_Action_Plan.md`, Line 177
- **Text:** `| **TOTAL PHASE 1-2** | **$556,400** |`
- **Issue:** The Go/No-Go report states software development costs as $506K, but the Software Action Plan's total Phase 1-2 cost is $556,400. The $506K figure does not match any subtotal in the Software Action Plan (labor subtotal is $428,400; non-labor subtotal is $128,000; labor + non-labor excluding management reserve is $515,400). No derivation produces $506K. Furthermore, $506K + $105K = $611K, but $556,400 + $105,000 = $661,400, not $611,000.
- **Fix:** Reconcile the figures. If the Software Action Plan's $556,400 is the authoritative number, the Go/No-Go report should read:
  - Change: `Software development ($506K) + 30 prototype units (30 x $3,500 = $105K) | ~$611,000`
  - To: `Software development (~$556K) + 30 prototype units (30 x $3,500 = $105K) | ~$661,000`
  - Then update all downstream figures that reference $611K (Lines 71, 95, 111, 114, 122) to ~$661K, and update the net cash flow figures accordingly.
  - Alternatively, if the Go/No-Go report excludes certain costs (e.g., management reserve or travel), document that assumption explicitly.

### ISSUE C-2 (CRITICAL): Phase 3 annual cost mismatch between Go/No-Go and Software Action Plan
- **File:** `01_Go_No_Go_Report.md`, Line 96
- **Text:** `~$1.3M/year`
- **File:** `02_Software_Action_Plan.md`, Line 190
- **Text:** `**$1,490,000**`
- **Issue:** The Go/No-Go report states Phase 3 costs as ~$1.3M/year, but the Software Action Plan shows $1,490,000 (i.e., ~$1.5M). The same $1.3M figure appears again in the cash flow table (Line 112). The discrepancy is $190,000.
- **Fix:** Update the Go/No-Go report to use `~$1.5M/year` in Lines 96 and 112 to match the Software Action Plan, or explicitly note that the Go/No-Go figure reflects Veteran Vectors scope only and excludes certain line items.

### ISSUE C-3 (MAJOR): Funding gap arithmetic is internally inconsistent
- **File:** `01_Go_No_Go_Report.md`, Line 114
- **Text:** `the consortium must fund ~$486,000 net before any OTA award`
- **Issue:** Line 111 shows cash flow: -$25,000 (submission) + (-$611,000 + $125,000) = -$511,000 cumulative net. But Line 114 states the funding gap is ~$486,000. The difference is $25,000, suggesting the $486K figure excludes the Tier 1 submission cost. This is confusing -- the funding gap should be stated consistently.
- **Fix:** Either:
  - (a) Change Line 114 to: `the consortium must fund ~$511,000 net before any OTA award (including submission costs)` to match the cash flow table; or
  - (b) Clarify: `the consortium must fund ~$486,000 net beyond submission costs before any OTA award` if the intent is to separate Tier 1.

### ISSUE C-4 (MAJOR): White Paper claims consortium partners without caveat; Go/No-Go says none confirmed
- **File:** `04_White_Paper.md`, Line 20
- **Text:** `Authentic Consortium (Medical Device OEM Partner, Cloud/Cyber Partner, Manufacturing Partner, Clinical SME Partner)`
- **File:** `04_White_Paper.md`, Lines 32, 55, 96, 124
- **Text:** Multiple references to "our medical device partner," "our cloud/cyber partner," "our manufacturing partner" as if these are confirmed entities.
- **File:** `01_Go_No_Go_Report.md`, Line 52
- **Text:** `IMPORTANT: As of February 24, 2026, no consortium partners have been formally committed.`
- **Issue:** The White Paper presents consortium partners as established facts ("our medical device partner provides..."), while the Go/No-Go report explicitly states no partners are confirmed. If the White Paper is submitted before partners are locked in, it makes claims the consortium cannot yet substantiate. An evaluator cross-referencing public information may question this.
- **Fix:** This is a known strategic tension. If partners are confirmed before submission (March 2), no change is needed. If partners are NOT confirmed by submission date, the White Paper language should be softened to conditional phrasing, e.g., "The consortium's medical device partner will provide..." or "The Authentic Consortium is structured to include a medical device OEM partner who will contribute..." However, note that conditional language weakens the proposal. The preferred fix is to confirm partners before submission per the Go/No-Go conditions.

### ISSUE C-5 (MINOR): "Authentic Consortium" naming inconsistency
- **File:** `01_Go_No_Go_Report.md`, Line 6
- **Text:** `Prepared for: Veteran Vectors (Prime) | Authentic Consortium`
- **File:** `01_Go_No_Go_Report.md`, Line 54
- **Text:** `Authentic Consortium Partners (Required -- Not Yet Confirmed)`
- **Issue:** The consortium name "Authentic Consortium" is used throughout all three documents, but the Go/No-Go report header says "Prepared for: Veteran Vectors (Prime) | Authentic Consortium," implying Veteran Vectors is separate from the consortium. In other places (e.g., White Paper Line 32), it says "Veteran Vectors, leading the Authentic Consortium." The relationship is clear from context, but the header phrasing could be more precise.
- **Fix:** Change Line 6 to: `Prepared for: Authentic Consortium | Veteran Vectors (Prime Contractor)` for clarity.

---

## 3. ACCURACY / CONTRADICTIONS

### ISSUE A-1 (MAJOR): White Paper performance claims presented as design targets but phrased as capabilities
- **File:** `04_White_Paper.md`, Line 39
- **Text:** `VitalEdge AI targets greater than 95% sensitivity for critical triage categories, to be validated through clinical simulation studies`
- **File:** `04_White_Paper.md`, Line 43
- **Text:** `with a design target of 15-30 minute advance warning before clinical onset`
- **File:** `01_Go_No_Go_Report.md`, Line 84
- **Text:** `The White Paper makes specific claims (>95% sensitivity, <50ms inference, 15-30 min early warning) that have not been validated against the proposed hardware platform.`
- **Issue:** The Go/No-Go report correctly identifies these as unvalidated claims. The White Paper itself does use "targets" and "design target" language (which is appropriate), but some phrasing still reads as capability statements rather than goals. For example, Line 39 says "VitalEdge AI targets greater than 95% sensitivity" -- this is acceptable. However, the overall Part 2 section title is "System Effectiveness," and an evaluator may interpret the content as claimed capabilities rather than design targets. The Go/No-Go report's concern is valid.
- **Fix:** Add a brief framing sentence at the beginning of Part 2: "The following performance parameters represent design targets to be validated during the prototype development phase. Validation methodology and acceptance criteria are detailed below." This pre-empts evaluator skepticism.

### ISSUE A-2 (MAJOR): DUNS field may be factually outdated
- **File:** `04_White_Paper.md`, Line 17
- **Text:** `| DUNS | [DUNS] |`
- **Issue:** The DUNS (Data Universal Numbering System) was officially replaced by the Unique Entity ID (UEI) in SAM.gov on April 4, 2022. If the DIU solicitation form still requests "DUNS," then keep it. If the solicitation uses current SAM.gov terminology, the field should be "UEI."
- **Fix:** Verify against the actual solicitation form. If UEI is requested, change `DUNS` to `UEI` and provide the SAM.gov Unique Entity ID.

### ISSUE A-3 (MAJOR): "140,000 patients/year capacity" claim lacks substantiation
- **File:** `04_White_Paper.md`, Line 97
- **Text:** `140,000 patients/year capacity: Cloud analytics tier architected for horizontal scaling via Kubernetes (EKS) auto-scaling.`
- **Issue:** The 140,000 patients/year figure appears only in the White Paper and is not referenced in either the Go/No-Go report or the Software Action Plan. There is no basis of estimate for this capacity claim -- no calculation showing how 15,000 units x some patient throughput = 140,000, or any cloud architecture sizing to support it.
- **Fix:** Either:
  - (a) Add a brief derivation, e.g., "Based on 15,000 deployed units each monitoring an average of 9-10 patients per year..." or
  - (b) Remove the specific number and replace with: "Cloud analytics tier architected for horizontal scaling to support full fleet deployment."
  - Option (b) is safer if the 140,000 figure cannot be substantiated.

### ISSUE A-4 (MINOR): "Propeller-based monitoring" for Zoll appears incorrect
- **File:** `01_Go_No_Go_Report.md`, Line 146
- **Text:** `Zoll: Propeller-based monitoring with existing military contracts.`
- **Issue:** Zoll Medical is known for defibrillators, CPR feedback devices, and patient monitoring -- not "propeller-based monitoring." This may be a confusion with "Propaq" (Zoll's Propaq line of vital signs monitors) or an AI-generated error. "Propeller-based" is not a recognized medical monitoring term.
- **Fix:** Change to: `Zoll: Propaq-based vital signs monitoring with existing military contracts.` (if referring to the Zoll Propaq MD or Propaq M series), or verify the intended product line and correct accordingly.

---

## 4. GRAMMAR & SPELLING

### ISSUE G-1 (MINOR): Inconsistent dash usage across documents
- **Files:** All three documents
- **Issue:** The documents inconsistently use double hyphens (`--`) for em dashes throughout. While this is consistent within itself (all three documents use `--`), it is not standard typographic practice. For a formal DoD submission, em dashes (---) or actual em dash characters should be used, depending on the final output format.
- **Fix:** If the final deliverable is rendered from Markdown to PDF or Word, ensure the rendering engine converts `--` to proper em dashes. If submitting as plain text or Markdown, the current `--` convention is acceptable but should be consistent (it is).

### ISSUE G-2 (MINOR): Awkward phrasing in White Paper introduction
- **File:** `04_White_Paper.md`, Line 30
- **Text:** `...without dependence on persistent network connectivity.`
- **Issue:** The phrase "without dependence on persistent network connectivity" is slightly awkward. More direct phrasing would improve readability.
- **Fix:** Change to: `...without requiring persistent network connectivity.`

### ISSUE G-3 (MINOR): Mixed use of "COTS" with and without expansion
- **File:** `04_White_Paper.md`, Lines 28, 64, 95, 101
- **Issue:** "COTS" is used multiple times but only expanded once (implicitly through context as "commercial off-the-shelf" in the Software Action Plan, never explicitly expanded in the White Paper). In a DoD-audience document, COTS is widely understood, but best practice is to expand on first use.
- **Fix:** On first use in the White Paper (Line 28), change `COTS-based hemodynamic sensors` to `commercial off-the-shelf (COTS) hemodynamic sensors`. Subsequent uses can remain as "COTS."

---

## 5. FORMATTING

### ISSUE F-1 (MAJOR): Software Action Plan total line has malformed table
- **File:** `02_Software_Action_Plan.md`, Lines 177-178
- **Text:**
  ```
  | **TOTAL PHASE 1-2** | **$556,400** |
  |---|---|
  ```
- **Issue:** The table separator `|---|---|` appears AFTER the total row (Line 178) rather than after a header row. This creates a malformed Markdown table. In standard Markdown, the `|---|---|` separator defines column alignment and must immediately follow the header row. Placing it after a data row will cause most Markdown renderers to start a new table or display incorrectly.
- **Fix:** Remove Line 178 (`|---|---|`). The total row should be the final row of the preceding non-labor cost table, separated by a blank line for visual distinction, or formatted as a standalone bold line:
  ```
  **TOTAL PHASE 1-2: $556,400**
  ```

### ISSUE F-2 (MINOR): White Paper formatting comment visible in document
- **File:** `04_White_Paper.md`, Line 1
- **Text:** `<!-- Formatting Notes for Conversion: Calibri 11pt font, 1-inch margins, maximum 5 pages -->`
- **Issue:** This HTML comment contains internal formatting instructions. While HTML comments are invisible in rendered Markdown, they would be visible if the file is opened in a plain-text editor or submitted as raw Markdown. If this document is converted to PDF/Word for submission, the comment should be removed to avoid accidental inclusion.
- **Fix:** Remove before final submission, or keep only if using an automated conversion pipeline that strips HTML comments.

### ISSUE F-3 (MINOR): Go/No-Go signature lines use generic underscores
- **File:** `01_Go_No_Go_Report.md`, Lines 182-184
- **Text:**
  ```
  **Decision Authority:** _________________________ (Veteran Vectors CEO/President)
  **Consortium Lead Concurrence:** _________________________ (Authentic Consortium Lead)
  ```
- **Issue:** The signature lines use underscores, which is appropriate for a printed document but may not render well in Markdown. If this is an internal document that will be printed and signed, this is acceptable. If it remains digital, consider using a different format.
- **Fix:** Acceptable as-is for print workflow. If digital-only, consider: `**Decision Authority:** [Signature / Date] -- Veteran Vectors CEO/President`

### ISSUE F-4 (MINOR): ASCII art diagrams may not render correctly in all viewers
- **File:** `02_Software_Action_Plan.md`, Lines 23-54, 206-275
- **Issue:** The architecture diagrams and data flow diagrams use ASCII art within code blocks. While this renders correctly in most Markdown viewers, the alignment depends on monospace font rendering. Some viewers may break alignment.
- **Fix:** Acceptable for internal documents. For final submission, consider converting to actual diagrams (PNG/SVG) if the submission format allows embedded images.

---

## 6. TONE

### ISSUE T-1 (INFO): Tone is generally appropriate for DoD audience
- **Files:** All three documents
- **Issue:** The tone across all three documents is professional, direct, and technically substantive -- appropriate for a DoD/DIU audience. The language avoids marketing fluff and maintains a mission-focused perspective. The White Paper's competitive differentiation section (Part 5) walks the line between advocacy and substance, but stays on the right side.
- **One note:** The phrase "competitive moat" (White Paper, Line 126) is Silicon Valley venture capital terminology. While DIU evaluators are familiar with commercial tech language, a more defense-appropriate alternative would be "competitive advantage" or "barriers to entry."
- **Fix (optional):** Change `VitalEdge AI's competitive moat includes` to `VitalEdge AI's sustainable competitive advantages include`.

---

## 7. COMPLETENESS

### ISSUE CO-1 (CRITICAL): White Paper lacks EtCO2 in sensor listing despite Software Action Plan including it
- **File:** `04_White_Paper.md`, Line 64
- **Text:** `Ruggedized COTS hemodynamic sensors (SpO2, continuous BP, HR, respiratory rate, temperature)`
- **File:** `02_Software_Action_Plan.md`, Line 52
- **Text:** `SpO2, BP, HR, Temp, EtCO2`
- **Issue:** The Software Action Plan's Device Tier architecture diagram lists EtCO2 (end-tidal CO2) as a sensor parameter, but the White Paper's Device Tier description omits EtCO2. This is a cross-document inconsistency and potentially a completeness gap -- EtCO2 is clinically important for respiratory assessment in TCCC and would strengthen the proposal.
- **Fix:** Add EtCO2 to the White Paper sensor listing. Change Line 64 to:
  `Ruggedized COTS hemodynamic sensors (SpO2, continuous BP, HR, respiratory rate, temperature, EtCO2)`
  Also verify that the sensor listing in White Paper Line 39 (which also omits EtCO2) is updated:
  Change `heart rate, SpO2, non-invasive blood pressure, respiratory rate, and skin temperature`
  To: `heart rate, SpO2, non-invasive blood pressure, respiratory rate, skin temperature, and end-tidal CO2 (EtCO2)`

### ISSUE CO-2 (MAJOR): White Paper does not address cybersecurity testing or penetration testing
- **File:** `04_White_Paper.md`, Lines 73-80 (Information Security section)
- **Issue:** The security section lists encryption, authentication, compliance frameworks, and supply chain measures. However, there is no mention of security testing methodology (penetration testing, vulnerability assessment, or continuous monitoring during development). The Software Action Plan mentions security scanning tools (Line 172) and STIG compliance, but the White Paper -- which is the external-facing document -- does not convey a security testing posture.
- **Fix:** Add one bullet to the Information Security section:
  `- Security testing: Automated STIG compliance scanning, dependency vulnerability analysis, and penetration testing during development and prior to fielding`

### ISSUE CO-3 (MAJOR): No mention of Section 508 / accessibility compliance in White Paper
- **File:** `04_White_Paper.md`
- **File:** `02_Software_Action_Plan.md`, Line 313
- **Text (SAP):** `Section 508: Cloud analytics dashboard and provider portal compliant with Section 508 / WCAG 2.1 AA`
- **Issue:** The Software Action Plan includes Section 508 compliance for the cloud dashboard, but the White Paper does not mention accessibility compliance at all. While this may not be a primary evaluation criterion for a combat medical device, Section 508 compliance is a federal requirement for IT systems.
- **Fix:** Minor -- not required for the White Paper given the 5-page limit and the fact that the primary user interface is the BATDOK tablet overlay. No change recommended unless page space permits.

### ISSUE CO-4 (MINOR): Go/No-Go report does not reference the Software Action Plan
- **File:** `01_Go_No_Go_Report.md`
- **Issue:** The Go/No-Go report provides financial figures that should trace to the Software Action Plan (e.g., the $506K software development cost), but never references the Software Action Plan as a supporting document. An executive reading the Go/No-Go report has no pointer to the detailed cost breakdown.
- **Fix:** Add a note in Section 4 (Financial Analysis): "Detailed software development cost breakdown provided in the Software Development Action Plan (PROJ00628-SAP-v1.1)."

---

## 8. CROSS-REFERENCE MATRIX

The following table summarizes key data points that should be consistent across documents:

| Data Point | Go/No-Go (Doc 01) | Software Action Plan (Doc 02) | White Paper (Doc 04) | Consistent? |
|---|---|---|---|---|
| Project ID | PROJ00628 | PROJ00628 | PROJ00628 | YES |
| Date | Feb 24, 2026 | Feb 24, 2026 | N/A (no date field) | YES |
| Prime contractor | Veteran Vectors | Veteran Vectors | Veteran Vectors LLC | YES (minor: LLC only in WP) |
| Consortium name | Authentic Consortium | Authentic Consortium | Authentic Consortium | YES |
| Product name | VitalEdge AI (Line 130) | N/A (not named) | VitalEdge AI | YES (but SAP never uses the product name) |
| Prototype units | 30 units by May 2026 | 30 units (Line 102) | 30 units (Line 95) | YES |
| Production scale | 15,000 units/yr by May 2027 | 15,000 units/yr (Line 117) | 15,000 units/yr (Line 96) | YES |
| Phase 1-2 SW cost | $506K | $556,400 | N/A | **NO -- $50K discrepancy** |
| Phase 3 annual cost | ~$1.3M | $1,490,000 | N/A | **NO -- $190K discrepancy** |
| Hardware unit cost (prototype) | $3,500 | N/A | ~$3,500 | YES |
| Software/unit at scale | N/A | $85/unit | $85 | YES |
| Total unit cost at scale | $2,500-$3,500 (gov price) | N/A | ~$1,035 (cost) | YES (different: cost vs. price) |
| AI model architecture | N/A | XGBoost + LSTM (v2) | N/A (not specified in WP) | N/A |
| Inference latency target | <50ms (Line 84) | <50ms (Line 80, 286) | <50ms (Line 85) | YES |
| Sensitivity target | >95% (Line 84) | >95% (Line 89) | >95% (Line 39) | YES |
| Specificity target | N/A | >85% (Line 89) | N/A | N/A |
| Early warning window | 15-30 min (Line 84) | 15-30 min (Line 83) | 15-30 min (Line 43) | YES |
| Battery life | 72hr (Line 41) | 72hr (Line 52) | 72hr (Line 64) | YES |
| BLE version | N/A | BLE 5.0+ (Line 306) | BLE 5.0 (Line 64) | YES |
| Sensors listed | N/A | SpO2, BP, HR, Temp, EtCO2 | SpO2, BP, HR, RR, Temp (no EtCO2) | **NO -- EtCO2 missing in WP** |
| Encryption standard | N/A | AES-256 / FIPS 140-3 (or 140-2) | AES-256 / FIPS 140-3 | MOSTLY (SAP hedges with 140-2) |
| Edge database | N/A | SQLite | SQLite | YES |
| Cloud database | N/A | PostgreSQL + TimescaleDB | TimescaleDB (Line 97) | YES |
| Multi-casualty capacity | N/A | 7-10 simultaneous (Line 262) | 7-10 simultaneous (Line 66) | YES |

---

## 9. PRIORITY ACTION ITEMS

### Must Fix Before Submission (Critical)
1. **Fill all placeholders** in White Paper (P-1 through P-4): Name, Phone, CAGE, DUNS/UEI
2. **Reconcile cost figures** between Go/No-Go ($506K) and Software Action Plan ($556,400) -- Issue C-1
3. **Reconcile Phase 3 cost** between Go/No-Go (~$1.3M) and Software Action Plan ($1,490,000) -- Issue C-2
4. **Add EtCO2** to White Paper sensor listings -- Issue CO-1

### Should Fix Before Submission (Major)
5. Correct funding gap arithmetic or clarify scope (Issue C-3)
6. Confirm consortium partner status aligns with White Paper language (Issue C-4)
7. Add design-target framing sentence to White Paper Part 2 (Issue A-1)
8. Verify DUNS vs. UEI per solicitation requirements (Issue A-2)
9. Substantiate or remove "140,000 patients/year" claim (Issue A-3)
10. Fix malformed table separator in Software Action Plan (Issue F-1)
11. Add cybersecurity testing mention to White Paper (Issue CO-2)
12. Add cross-reference to Software Action Plan in Go/No-Go report (Issue CO-4)

### Recommended Improvements (Minor/Info)
13. Correct "Propeller-based" to "Propaq-based" for Zoll (Issue A-4)
14. Expand COTS on first use in White Paper (Issue G-3)
15. Change "competitive moat" to "competitive advantages" (Issue T-1)
16. Improve phrasing: "without dependence on" to "without requiring" (Issue G-2)
17. Remove HTML formatting comment before submission (Issue F-2)

---

*End of AI Quality Check Results*
*Generated: February 24, 2026*
